Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Newburyport › NPI 1992779482
Hospital

Anna Jaques Hospital

Anna Jaques Hospital was paid $12.84M by Medicaid between Jan 2018 and Dec 2024, across 237 billing codes. Its largest line is 99285, emergency room visit (most serious) — 13% of everything it billed.

33Billing provider infoANNA JAQUES HOSPITAL
NEWBURYPORT, MA 01950
33aNPI1992779482assigned 02/14/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$12.84M
24GClaims629,497
24DCodes billed237
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in Massachusetts

Rank by total paid#2 of 27
Median peer was paid$138K
This provider vs. median93×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201888,053$1.79M
201995,553$1.81M
202064,113$987K
2021109,268$2.19M
2022105,276$2.44M
202392,956$1.88M
2024incomplete74,278$1.75M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 14,933 13,270 $1.70M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 11,521 10,692 $1.43M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.3% 9,304 8,556 $1.06M
96361 Intravenous infusion, hydration; each additional hour 5.9% 3,262 2,315 $762K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.8% 10,162 3,177 $483K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3.5% 16,843 13,761 $455K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.1% 3,686 3,449 $398K
77063 Screening digital breast tomosynthesis, bilateral 3.0% 6,387 6,327 $379K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2.8% 2,881 2,656 $365K
70450 Computed tomography, head or brain; without contrast material 2.3% 3,857 3,512 $294K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.2% 10,907 10,110 $280K
71046 Radiologic examination, chest; 2 views 2.1% 10,802 10,270 $275K
225 more codes
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.7% 8,590 $221K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.6% 1,618 $207K
76830 Ultrasound, transvaginal 1.4% 1,863 $180K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.4% 48,681 $179K
99214 Doctor's office visit, returning patient (more involved) 1.4% 1,210 $179K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 1,259 $156K
S9485 Crisis intervention mental health services, per diem 1.2% 348 $151K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.1% 1,279 $146K
84443 Thyroid stimulating hormone (TSH) 1.0% 16,125 $131K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,752 $125K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,735 $124K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,420 $122K
80053 Comprehensive metabolic panel <1% 28,534 $120K
77067 Screening mammography, bilateral, including computer-aided detection <1% 6,405 $112K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,911 $107K
99213 Doctor's office visit, returning patient (routine) <1% 841 $86K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,132 $84K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 5,046 $81K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,065 $80K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,545 $73K
74018 <1% 1,825 $71K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,023 $71K
99441 <1% 743 $70K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,689 $67K
93971 <1% 365 $60K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 627 $56K
83036 Hemoglobin; glycosylated (A1C) <1% 11,646 $53K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,054 $51K
80048 Basic metabolic panel (calcium, ionized) <1% 20,412 $50K
72100 <1% 1,448 $49K
73562 <1% 1,753 $49K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 598 $49K
87480 <1% 3,383 $48K
87660 <1% 3,387 $48K
87510 <1% 3,383 $47K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,299 $47K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,596 $41K
76642 <1% 407 $39K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,873 $38K
20610 <1% 294 $37K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,705 $35K
84484 <1% 6,732 $34K
82728 <1% 4,276 $34K
80061 Lipid panel <1% 16,768 $31K
73630 <1% 1,141 $31K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,688 $29K
86803 <1% 3,024 $29K
82607 <1% 3,885 $29K
62323 <1% 131 $28K
ATP14 <1% 5,634 $28K
76819 Fetal biophysical profile; without non-stress testing <1% 312 $27K
84439 <1% 5,444 $25K
ATP08 <1% 5,207 $25K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 55 $24K
97161 <1% 520 $24K
83690 <1% 6,495 $23K
0002A <1% 841 $23K
81025 <1% 4,622 $23K
0001A <1% 1,000 $23K
84702 <1% 1,868 $22K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 105 $21K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 273 $20K
80050 General health panel <1% 1,486 $20K
73610 <1% 633 $19K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 183 $18K
76536 <1% 207 $17K
59025 Fetal non-stress test <1% 95 $17K
71275 Computed tomographic angiography, chest, with contrast material <1% 182 $17K
G0378 Hospital observation service, per hour <1% 971 $17K
96375 Therapeutic injection; each additional sequential IV push <1% 6,752 $16K
97597 <1% 640 $16K
73130 <1% 526 $15K
87070 <1% 2,889 $15K
83735 <1% 4,824 $14K
81003 <1% 12,557 $14K
82948 <1% 6,125 $13K
83550 <1% 3,084 $13K
83540 <1% 3,838 $13K
ATP15 <1% 1,968 $12K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 151 $12K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 594 $11K
82746 <1% 1,301 $10K
97035 <1% 250 $10K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 55 $10K
73030 <1% 391 $9K
94664 <1% 369 $9K
71045 Radiologic examination, chest; single view <1% 2,385 $9K
76801 <1% 90 $9K
36415 Collection of venous blood by venipuncture <1% 55,439 $9K
84481 <1% 1,013 $9K
81001 <1% 5,620 $9K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 618 $8K
73110 <1% 215 $8K
83880 <1% 860 $8K
72125 Computed tomography, cervical spine; without contrast material <1% 976 $8K
80076 <1% 6,687 $8K
64635 <1% 51 $7K
87186 <1% 1,857 $7K
84403 <1% 309 $7K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 327 $7K
ATP17 <1% 4,568 $6K
73502 <1% 224 $6K
85610 <1% 4,546 $6K
83605 <1% 1,453 $6K
82043 <1% 3,179 $6K
87340 <1% 804 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 312 $6K
J2704 Injection, propofol, 10 mg <1% 7,258 $5K
87040 <1% 660 $5K
86140 <1% 1,789 $5K
86850 <1% 905 $5K
80081 <1% 78 $5K
0011A <1% 165 $5K
82570 <1% 1,803 $5K
85651 <1% 2,180 $5K
87077 <1% 1,332 $4K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,294 $4K
ATP03 <1% 1,481 $4K
76770 <1% 40 $4K
85379 <1% 836 $4K
86706 <1% 483 $4K
84270 <1% 212 $4K
77080 <1% 65 $3K
86592 <1% 1,023 $3K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 72 $3K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 371 $3K
0012A <1% 124 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,358 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,775 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,777 $3K
86618 <1% 260 $3K
73140 <1% 41 $3K
97162 <1% 66 $3K
Q3014 Telehealth originating site facility fee <1% 1,513 $3K
99219 <1% 96 $3K
86704 <1% 276 $3K
87147 <1% 615 $2K
77066 Tomosynthesis, mammo <1% 25 $2K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 52 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 13 $2K
94761 <1% 4,530 $2K
86900 <1% 1,081 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 60 $2K
86709 <1% 210 $2K
86901 <1% 1,082 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,020 $2K
71250 <1% 101 $2K
97164 <1% 26 $1K
84153 <1% 199 $1K
87522 Neg quan hep c or qual rna <1% 39 $1K
94726 <1% 13 $1K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 44 $1K
83516 <1% 107 $1K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 14 $1K
87205 <1% 539 $1K
84703 <1% 220 $1K
93041 <1% 853 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 16 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,378 $1K
71271 <1% 13 $995.90
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 518 $950.46
83520 <1% 27 $927.48
88342 <1% 26 $909.80
85027 <1% 188 $799.40
94760 <1% 3,765 $705.60
77065 Tomosynthesis, mammo <1% 12 $654.88
J2270 Injection, morphine sulfate, up to 10 mg <1% 960 $654.74
82950 <1% 165 $641.07
86038 <1% 66 $617.65
82784 <1% 104 $596.84
83001 <1% 38 $551.87
ATP18 <1% 406 $537.53
84466 <1% 49 $486.30
84146 <1% 57 $433.38
64636 <1% 52 $408.24
82565 <1% 828 $375.46
83970 <1% 12 $372.19
72050 <1% 13 $362.05
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,344 $343.83
82248 <1% 223 $313.56
85730 <1% 132 $313.32
J7120 Ringers lactate infusion, up to 1000 cc <1% 30 $298.80
87088 <1% 52 $285.23
72070 <1% 13 $283.92
82150 <1% 41 $204.28
83986 <1% 89 $203.18
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 1,035 $203.08
84560 <1% 111 $187.79
J1040 Injection, methylprednisolone acetate, 80 mg <1% 1,068 $179.24
J0690 Injection, cefazolin sodium, 500 mg <1% 951 $174.14
J1030 Injection, methylprednisolone acetate, 40 mg <1% 1,856 $166.08
J2060 Injection, lorazepam, 2 mg <1% 158 $148.81
96376 <1% 2,008 $132.24
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 59 $119.55
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 12 $115.83
ATP09 <1% 30 $89.60
80164 <1% 31 $74.10
84450 <1% 144 $72.81
ATP07 <1% 24 $67.44
J1010 Injection, methylprednisolone acetate, 1 mg <1% 291 $56.83
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,317 $47.11
84460 <1% 300 $41.07
84520 <1% 448 $31.31
84100 <1% 135 $30.37
ATP11 <1% 12 $27.33
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 928 $16.33
83615 <1% 25 $12.46
82947 <1% 29 $12.15
82040 <1% 14 $9.02
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 40 $0.90
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 126 $0.01
80320 0% 447 $0.00
82550 0% 13 $0.00
G0008 Administration of influenza virus vaccine 0% 28 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 115 $0.00
81015 0% 16 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 18 $0.00
J3490 Unclassified drugs 0% 16 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 0% 39 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 115 $0.00
98960 0% 66 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 396 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 170 $0.00
87150 0% 17 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 57 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialOCONNOR, DELIA (PRESIDENT & CEO)
Same official

Other billing entities under OCONNOR, DELIA

Full network →
ProviderLocationPaid
Anna Jaques HospitalNewburyport, MA$1.35M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.